Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Impaired Il-23–Dependent Induction of Ifn-Γ Underlies Mycobacterial Disease in Patients With Inherited Tyk2 Deficiency Publisher Pubmed



Ogishi M1 ; Arias AA1, 2, 3 ; Yang R1 ; Han J1 ; Zhang P1 ; Rinchai D1 ; Halpern J1 ; Mulwa J1 ; Keating N1, 4 ; Chrabieh M5, 6 ; Laine C5, 6 ; Seeleuthner Y5, 6 ; Ramirezalejo N1 ; Nekooiemarnany N7 Show All Authors
Authors
  1. Ogishi M1
  2. Arias AA1, 2, 3
  3. Yang R1
  4. Han J1
  5. Zhang P1
  6. Rinchai D1
  7. Halpern J1
  8. Mulwa J1
  9. Keating N1, 4
  10. Chrabieh M5, 6
  11. Laine C5, 6
  12. Seeleuthner Y5, 6
  13. Ramirezalejo N1
  14. Nekooiemarnany N7
  15. Guennoun A8
  16. Mullerfleckenstein I9
  17. Fleckenstein B9
  18. Kilic SS10
  19. Minegishi Y11
  20. Ehl S12
  21. Kaiserlabusch P13
  22. Kendirdemirkol Y14
  23. Rozenberg F15
  24. Errami A16
  25. Zhang SY1, 5, 6
  26. Zhang Q1, 5, 6
  27. Bohlen J5, 6
  28. Philippot Q5, 6
  29. Puel A1, 5, 6
  30. Jouanguy E1, 5, 6
  31. Pourmoghaddas Z17
  32. Bakhtiar S18
  33. Willasch AM18
  34. Horneff G19, 20
  35. Llanora G21
  36. Shek LP21, 22
  37. Chai LYA23, 24, 25
  38. Tay SH25, 26
  39. Rahimi HH27
  40. Mahdaviani SA28
  41. Nepesov S29
  42. Bousfiha AA30
  43. Erdeniz EH31
  44. Karbuz A32
  45. Marr N8
  46. Navarrete C33
  47. Adeli M34
  48. Hammarstrom L35, 36, 37
  49. Abolhassani H35, 37
  50. Parvaneh N37
  51. Al Muhsen S38
  52. Alosaimi MF38
  53. Alsohime F39, 40
  54. Nourizadeh M41, 42
  55. Moin M41, 42
  56. Arnaout R43, 44
  57. Alshareef S43
  58. Elbaghdadi J45
  59. Genel F46
  60. Sherkat R7
  61. Kiykim A47
  62. Yucel E48
  63. Keles S49
  64. Bustamante J1, 5, 50
  65. Abel L1, 5, 6
  66. Casanova JL1, 5, 6, 51, 52
  67. Boissondupuis S1, 5, 6
Show Affiliations
Authors Affiliations
  1. 1. St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, United States
  2. 2. Primary Immunodeficiencies Group, University of Antioquia, Medellin, Colombia
  3. 3. School of Microbiology, University of Antioquia, Medellin, Colombia
  4. 4. Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Melbourne, Australia
  5. 5. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
  6. 6. Paris Cite University, Imagine Institute, Paris, France
  7. 7. Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  8. 8. Sidra Medicine, Doha, Qatar
  9. 9. Institute of Clinical and Molecular Virology, University of Erlangen-Nuremberg, Erlangen, Germany
  10. 10. Department of Pediatric Immunology and Rheumatology, Faculty of Medicine, Uludag University, Bursa, Turkiye
  11. 11. Division of Molecular Medicine, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan
  12. 12. Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  13. 13. Eltern-Kind-Zentrum Prof. Hess, Klinikum Bremen–Mitte, Bremen, Germany
  14. 14. Department of Pediatric Genetics, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkiye
  15. 15. Laboratory of Virology, Assistance Publique-Hopitaux de Paris, Cochin Hospital, Paris, France
  16. 16. Laboratory of Clinical Immunology, Inflammation and Allergy, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco
  17. 17. Department of Pediatric Infectious Disease, Isfahan University of Medical Sciences, Isfahan, Iran
  18. 18. Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Department for Child and Adolescent Medicine, University Hospital Frankfurt, Frankfurt, Germany
  19. 19. Center for Pediatric Rheumatology, Department of Pediatrics, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany
  20. 20. Medical Faculty, University of Cologne, Cologne, Germany
  21. 21. Division of Allergy and Immunology, Department of Paediatrics, Khoo Teck Puat-National University Children’s Medical Institute, National University Health System, Singapore
  22. 22. Department of Pediatrics, National University of Singapore, Singapore
  23. 23. Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore
  24. 24. Synthetic Biology for Clinical and Technological Innovation, Life Sciences Institute, Synthetic Biology Translational Research Program, National University of Singapore, Singapore
  25. 25. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  26. 26. Division of Rheumatology, Department of Medicine, National University Hospital, Singapore
  27. 27. Department of Pediatrics, Isfahan University of Medical Sciences, Isfahan, Iran
  28. 28. Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  29. 29. Department of Pediatric Allergy and Immunology, Istanbul Medipol University, Istanbul, Turkiye
  30. 30. Clinical Immunology Unit, Department of Pediatrics, King Hassan II University, Ibn-Rochd Hospital, Casablanca, Morocco
  31. 31. Division of Pediatric Infectious Diseases, Ondokuz Mayis University, Samsun, Turkiye
  32. 32. Division of Pediatric Infectious Diseases, Okmeydani Training and Research Hospital, University of Health Sciences, Istanbul, Turkiye
  33. 33. Department of Immunology, Hospital de Ninos Roberto del Rio, Santiago de Chile, Chile
  34. 34. Division of Allergy and Immunology, Sidra Medicine/Hamad Medical Corp., Doha, Qatar
  35. 35. Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden
  36. 36. Beijing Genomics Institute, Shenzhen, China
  37. 37. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  38. 38. Immunology Research Laboratory, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia
  39. 39. Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
  40. 40. Pediatric Intensive Care Unit, King Saud University Medical City, Riyadh, Saudi Arabia
  41. 41. Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  42. 42. Children’s Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
  43. 43. Section of Allergy & Immunology, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  44. 44. Al Faisal University, Riyadh, Saudi Arabia
  45. 45. Genetics Unit, Mohamed V Military Hospital, Hay Riad, Rabat, Morocco
  46. 46. University of Health Sciences, Dr Behcet Uz Children’s Hospital, Division of Pediatric Immunology, Izmir, Turkiye
  47. 47. Pediatric Allergy and Immunology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkiye
  48. 48. Division of Pediatric Allergy and Immunology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkiye
  49. 49. Division of Pediatric Allergy and Immunology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkiye
  50. 50. Center for the Study of Primary Immunodeficiencies, Assistance Publique-Hopitaux de Paris, Necker Hospital for Sick Children, Paris, France
  51. 51. Howard Hughes Medical Institute, New York, NY, United States
  52. 52. Deparment of Pediatrics, Necker Hospital for Sick Children, Paris, France

Source: Journal of Experimental Medicine Published:2022


Abstract

Human cells homozygous for rare loss-of-expression (LOE) TYK2 alleles have impaired, but not abolished, cellular responses to IFN-α/β (underlying viral diseases in the patients) and to IL-12 and IL-23 (underlying mycobacterial diseases). Cells homozygous for the common P1104A TYK2 allele have selectively impaired responses to IL-23 (underlying isolated mycobacterial disease). We report three new forms of TYK2 deficiency in six patients from five families homozygous for rare TYK2 alleles (R864C, G996R, G634E, or G1010D) or compound heterozygous for P1104A and a rare allele (A928V). All these missense alleles encode detectable proteins. The R864C and G1010D alleles are hypomorphic and loss-of-function (LOF), respectively, across signaling pathways. By contrast, hypomorphic G996R, G634E, and A928V mutations selectively impair responses to IL-23, like P1104A. Impairment of the IL-23–dependent induction of IFN-γ is the only mechanism of mycobacterial disease common to patients with complete TYK2 deficiency with or without TYK2 expression, partial TYK2 deficiency across signaling pathways, or rare or common partial TYK2 deficiency specific for IL-23 signaling. © 2022 Ogishi et al.
Other Related Docs
20. Role of Rare Immune Cells in Common Variable Immunodeficiency, Pediatric Allergy and Immunology (2022)
21. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort, Journal of Allergy and Clinical Immunology: In Practice (2019)